On the Horizon (INCLUDING Stem Cells)
Let’s Talk Stem Cells
The term stem cell therapies is commonly used interchangeably with regenerative medicine. However, it is separate and only a small fraction of the research and practice of regenerative medicine.
Why Adipose-Derived Stem Cells (ADSCs) are Valuable
- They have self-renewing properties
- They have no risk of rejection when injected back into the donor
- They do not trigger an immune response
- They can be used in a variety of places in the body due to their ability to differentiate themselves (organs, joints, skin, muscles, etc.)
Current estimates suggest that the stem cell segment, currently valued at $600M, is on a trajectory of significant growth at a 20% CAGR*. This figure, however, is a conservative estimate, considering the nearly 4,000 therapies in development. This potential growth should inspire optimism and hope for the future of regenerative medicine.
T&CT is committed to the future of stem cell research and application. Our ADIPOSET® Platform allows for long-term adiposet tissue storage as the science grows.
Regenerative Medicine - A New Era of Healing
Regenerative Medicine is a revolution that promises to radically change human health and overturn centuries of focus on surgical and pharmacological interventions.
Imagine a world where damaged organs are not just repaired – but renewed. Where chronic diseases are managed and cured, this is the promise of regenerative medicine.
The central focus of Regenerative Medicine is human cells and their self-healing properties.
What is Regenerative Medicine?
Regenerative Medicine is an emerging interdisciplinary field of research and clinical applications focused on the incredible power of human cells. By understanding and manipulating these building blocks of life, scientists and doctors are developing therapies that can replace damaged tissues, stimulate the body’s repair mechanisms, and even help regenerate organs.
THE POSSIBILITIES OF Regenerative Medicine
- The body's self-healing, repair, replacement, or regeneration of cells and injured tissues
- Repairing diseased and damaged organs
- Restoring function, despite the cause (congenital disabilities, disease, diabetes, cardiovascular diseases, trauma, dermal wounds, aging, as well as certain types of cancer, and more)
It's No Longer Science Fiction
Regenerative medicine is already making a difference in the treatment of conditions ranging from heart disease to diabetes to spinal cord injuries. With a market valued at over $35 billion and growing rapidly, it’s clear that this field is poised to transform how we approach healthcare in the 21st century. Estimates value the total worldwide Reconstructive Medicine market at $35 billion, growing at a CAGR* of 25%.
The discipline of reconstructive medicine uses a combination of technological approaches that move it beyond traditional transplantation and replacement therapies, including:
- Gene therapy
- Stem cell transplantation
- Tissue engineering
- Reprogramming of cell and tissue types, including the use of materials and de novo generated cells,
- As well as various combinations of the above to take the place of missing tissue, effectively replacing it both structurally and functionally
- Tissue healing
Tissue Engineering
The terms “tissue engineering” and “regenerative medicine” have become largely interchangeable, as the field hopes to focus on cures instead of treatments for complex, often chronic, diseases.
Tissue engineering evolved from biomaterials development and refers to combining scaffolds, cells, and biologically active molecules into functional tissues.
Tissue engineering aims to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs.
TISSUE ENGINEERING May Involve
- Transplanting stem cells, progenitor cells, or tissue, stimulating the body's repair processes
- Using cells as delivery vehicles for therapeutic agents such as genes and cytokines
- Using biomaterials and tissue engineering to support tissue regeneration.
- Leveraging the body's innate healing response to promote regeneration
Effective long-term, large-volume storage is a crucial pillar for future advances.
It has been a missing piece of the jigsaw until now.
T&CT has the solution.
All regenerative medicine strategies depend on harnessing, stimulating, or guiding the body’s developmental or repair processes. Accordingly, stem cell research plays a central role in regenerative medicine, which also spans the disciplines of tissue engineering, developmental cell biology, cellular therapeutics, gene therapy, and biomaterials (scaffolds and matrices).
Advances in Regenerative Medicine are driven by the limitations in the availability of most specialist cells and the constraints on the expansion and manipulation of adult stem cells.
Low yields post-storage, loss of function or viability, and damage to essential tissue architecture all lead to failure or poorer tissue performance. We believe these challenges can be overcome with improved storage techniques like the ADIPOSET® System.